Literature DB >> 19469830

EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias.

H F Harbo1, J Finsterer, J Baets, C Van Broeckhoven, S Di Donato, B Fontaine, P De Jonghe, A Lossos, T Lynch, C Mariotti, L Schöls, A Spinazzola, Z Szolnoki, S J Tabrizi, C Tallaksen, M Zeviani, J-M Burgunder, T Gasser.   

Abstract

BACKGROUND AND
PURPOSE: These EFNS guidelines on the molecular diagnosis of neurogenetic disorders are designed to provide practical help for the general neurologist to make appropriate use of molecular genetics in diagnosing neurogenetic disorders. Since the publication of the first two EFNS-guideline papers on the molecular diagnosis of neurological diseases in 2001, rapid progress has been made in this field, necessitating an updated series of guidelines.
METHODS: Literature searches were performed before expert members of the task force wrote proposals, which were discussed in detail until final consensus had been reached among all task force members. RESULTS AND
CONCLUSION: This paper provides updated guidelines for molecular diagnosis of Huntington's disease, Parkinson's disease and dystonias as well as a general introduction to the topic. Possibilities and limitations of molecular genetic diagnosis of these disorders are evaluated and recommendations are provided.

Entities:  

Mesh:

Year:  2009        PMID: 19469830     DOI: 10.1111/j.1468-1331.2009.02646.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

1.  Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases.

Authors:  Sarah Jesse; Johannes Brettschneider; Sigurd D Süssmuth; Bernhard G Landwehrmeyer; Christine A F von Arnim; Albert C Ludolph; Hayrettin Tumani; Markus Otto
Journal:  J Neurol       Date:  2010-12-25       Impact factor: 4.849

Review 2.  Genetics of Parkinson's disease.

Authors:  Christine Klein; Ana Westenberger
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Parkinson disease: genetic testing in Parkinson disease-who should be assessed?

Authors:  Christine Klein; Ana Djarmati
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

Review 4.  Genetics of primary torsion dystonia.

Authors:  Norbert Brüggemann; Christine Klein
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

Review 5.  What is the role of genetic testing in movement disorders practice?

Authors:  Susanne A Schneider; Christine Klein
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

6.  Neurogenetics in Argentina: diagnostic yield in a personalized research based clinic.

Authors:  Sergio Alejandro Rodríguez-Quiroga; Marta Cordoba; Dolores González-Morón; Nancy Medina; Patricia Vega; Cecilia Vazquez Dusefante; Tomoko Arakaki; Nélida Susana Garretto; Marcelo Andres Kauffman
Journal:  Genet Res (Camb)       Date:  2015       Impact factor: 1.588

7.  Predictive value of dopamine transporter SPECT imaging with [¹²³I]PE2I in patients with subtle parkinsonian symptoms.

Authors:  Morten Ziebell; Birgitte B Andersen; Gerda Thomsen; Lars H Pinborg; Merete Karlsborg; Steen G Hasselbalch; Gitte M Knudsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-18       Impact factor: 9.236

8.  Recent advances in the management of choreas.

Authors:  Jean-Marc Burgunder
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 9.  Genetic Testing for Parkinson Disease: Are We Ready?

Authors:  Lola Cook; Jeanine Schulze; Catherine Kopil; Tara Hastings; Anna Naito; Joanne Wojcieszek; Katelyn Payne; Roy N Alcalay; Christine Klein; Rachel Saunders-Pullman; Tatyana Simuni; Tatiana Foroud
Journal:  Neurol Clin Pract       Date:  2021-02

10.  The commercial genetic testing landscape for Parkinson's disease.

Authors:  Lola Cook; Jeanine Schulze; Jennifer Verbrugge; James C Beck; Karen S Marder; Rachel Saunders-Pullman; Christine Klein; Anna Naito; Roy N Alcalay
Journal:  Parkinsonism Relat Disord       Date:  2021-10-19       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.